Literature DB >> 23411069

Profile of lower urinary tract symptoms in the male and their impact on quality of life.

J Cambronero1, S Arlandis, C Errando, A M Mora.   

Abstract

OBJECTIVES: Following current European Guidelines, Lower Urinary Tract Symptoms (LUTS) are produced by several causes and, thus, thorough clinical assessment should be undertaken for a correct therapeutic management. This study was conducted in order to assess the symptoms profile and their impact on Health-Related Quality of Life (HRQL) of male patients attending urology outpatient clinics.
MATERIAL AND METHODS: Epidemiological, cross-sectional study including adult male patients (n=826) presenting with at least one de novo previously untreated LUTS. Socio-demographic and clinical variables were collected. Patients completed IPSS, Bladder Control Self-Assessment Questionnaire (B-SAQ) and SF-12 questionnaires.
RESULTS: Mean age (SD) was 65 (10) years. A combination of storage, voiding and post-micturition symptoms were present in 69% of subjects and 30% showed >2 urgency episodes and >6 micturitions daily (storage symptoms -SS- sub-population). Storage symptoms were the reason for consultation in 86%. Mean peak urinary flow (Q(max)) was 11.4 mL/s, in 44% of patients,prostate volume was 20-40 mL and 91% showed moderate or severe symptoms on IPSS with an overall mean (SD) score of 17 (7). SS sub-population had higher B-SAQ scores (6,9 vs 4,8 for symptoms; 7,8 vs 5,1 for bother), and worse HRQL (IPSS item 8).
CONCLUSIONS: These findings support the importance of addressing treatment adequately according to patient profile, bothersomeness and impact on HRQL.
Copyright © 2012 AEU. Published by Elsevier Espana. All rights reserved.

Entities:  

Keywords:  Calidad de vida; Lower urinary tract symptoms; Male; Quality of life; Síntomas del tracto urinario inferior; Urology; Urología; Varón

Mesh:

Year:  2013        PMID: 23411069     DOI: 10.1016/j.acuro.2012.11.011

Source DB:  PubMed          Journal:  Actas Urol Esp        ISSN: 0210-4806            Impact factor:   0.994


  4 in total

1.  [Prevalence and characterization of overactive bladder detected in a population in Madrid with self-administered OAB-V3 questionnaire in Primary Care].

Authors:  Javier C Angulo; María P Calderín; Yolanda Fernández; Miriam González; Esther Gómez; Maria B Herreros; Purificación Peñasco; Manuela Zapatero; Juan F Dorado
Journal:  Aten Primaria       Date:  2017-07-24       Impact factor: 1.137

2.  2013 Annual National Digital Rectal Exam Day: impact on prostate health awareness and disease detection.

Authors:  Michael E Chua; Marie Carmela M Lapitan; Marcelino L Morales; Aristotle Bernard Maniego Roque; John Kenneth Domingo
Journal:  Prostate Int       Date:  2014-03-30

3.  Resource utilization and costs associated with the addition of an antimuscarinic in patients treated with an alpha-blocker for the treatment of urinary symptoms linked to benign prostatic hyperplasia.

Authors:  Antoni Sicras-Mainar; Ruth Navarro-Artieda; Ana Mª Mora; Marta Hernández
Journal:  BMC Urol       Date:  2017-09-12       Impact factor: 2.264

4.  A retrospective analysis comparing persistence and adherence to treatment with free- vs fixed-dose combination of an alpha blocker and an antimuscarinic agent in men with LUTS in Spain.

Authors:  Margarita Landeira; Ana M Mora Blázquez; Rodrigo Martins de Almeida; Patrick J O Covernton; José Medina-Polo; Antonio Alcántara Montero
Journal:  Int J Clin Pract       Date:  2020-09-19       Impact factor: 3.149

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.